Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account.
暂无分享,去创建一个
J. Wilschut | T. Daemen | H. Nijman | M. J. Postma | T. A. Westra | J. Luttjeboer | T. Westra | M. Postma | Jan C Wilschut | H. W. Nijman